Efficacy and Safety of Pharmaceutically Manufactured Cannabidiol in Recurrent Pericarditis: A Phase II Clinical Trial
- DOI
- 10.1161/jaha.125.047605
- Published
- 2026-07-21
- Container
- Journal of the American Heart Association
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1161/jaha.125.047605,
title = {Efficacy and Safety of Pharmaceutically Manufactured Cannabidiol in Recurrent Pericarditis: A Phase II Clinical Trial},
author = {Sushil Allen Luis and Allan L. Klein and Paul C. Cremer and Antonio Abbate and Jonathan R. Salik and Georgia K. Thomas and Syed Waqas Haider and Tracy E. Hagerty and David Lin and Thomas E. Waggoner and Stephen J. Nicholls and Bridget‐Anne Kirwan and Kelly A. D. Narine and Andrea B. Parker and Andrew Hamer},
year = {2026},
journal = {Journal of the American Heart Association},
doi = {10.1161/jaha.125.047605},
url = {https://doi.org/10.1161/jaha.125.047605}
}RIS
TY - JOUR TI - Efficacy and Safety of Pharmaceutically Manufactured Cannabidiol in Recurrent Pericarditis: A Phase II Clinical Trial AU - Sushil Allen Luis AU - Allan L. Klein AU - Paul C. Cremer AU - Antonio Abbate AU - Jonathan R. Salik AU - Georgia K. Thomas AU - Syed Waqas Haider AU - Tracy E. Hagerty AU - David Lin AU - Thomas E. Waggoner AU - Stephen J. Nicholls AU - Bridget‐Anne Kirwan AU - Kelly A. D. Narine AU - Andrea B. Parker AU - Andrew Hamer PY - 2026 JO - Journal of the American Heart Association DO - 10.1161/jaha.125.047605 UR - https://doi.org/10.1161/jaha.125.047605 ER -
APA
Luis, S. A., Klein, A. L., Cremer, P. C., Abbate, A., Salik, J. R., Thomas, G. K., Haider, S. W., Hagerty, T. E., Lin, D., Waggoner, T. E., Nicholls, S. J., Kirwan, B., Narine, K. A. D., Parker, A. B., & Hamer, A. (2026). Efficacy and Safety of Pharmaceutically Manufactured Cannabidiol in Recurrent Pericarditis: A Phase II Clinical Trial. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.047605
Source records
- crossref · retrieved 2026-09-26T11:28:18.834Z